JPS59175423A - Cariostatic agent - Google Patents

Cariostatic agent

Info

Publication number
JPS59175423A
JPS59175423A JP5120183A JP5120183A JPS59175423A JP S59175423 A JPS59175423 A JP S59175423A JP 5120183 A JP5120183 A JP 5120183A JP 5120183 A JP5120183 A JP 5120183A JP S59175423 A JPS59175423 A JP S59175423A
Authority
JP
Japan
Prior art keywords
acid
agent
synthetic
lactone
corrosion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5120183A
Other languages
Japanese (ja)
Other versions
JPH0567608B2 (en
Inventor
Keiji Iguchi
井口 圭二
Masayoshi Fukuda
福田 正佳
Koichi Ogata
浩一 尾形
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KANEBO SHOKUHIN KK
Kracie Foods Ltd
Original Assignee
KANEBO SHOKUHIN KK
Kanebo Foods Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KANEBO SHOKUHIN KK, Kanebo Foods Ltd filed Critical KANEBO SHOKUHIN KK
Priority to JP5120183A priority Critical patent/JPS59175423A/en
Publication of JPS59175423A publication Critical patent/JPS59175423A/en
Publication of JPH0567608B2 publication Critical patent/JPH0567608B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE:To provide a safe cariostatic agent absolutely free of side effect, by using a synthetic perfumery as it is, or combining the perfumery properly with a flavoring agent such as carboxylic acid, lactone, etc., i.e. a food flavor. CONSTITUTION:The objective cariostatic agent contains (A) one or more synthetic perfumes selected from cresyl acetate, cyclamen aldehyde, isoeugenol, methyleugenol, heriotropin, ethyl salicylate, n-decanal and p-methylacetophenone, or contains the component (A) in combination with one or more components selected from (B) one or more carboxylic acids selected from caprylic acid, lauric acid, myristic acid, palmitic acid, stearic acid, etc. and (C) one or more lactones selected from d-decalactone, d-dodecalactone, d-undecalactone, d-tridecalactone, etc. EFFECT:Excellent effect can be attained by the use of a slight amount of the agent.

Description

【発明の詳細な説明】 この発明は、抗頗蝕剤、す、なわち鮎蝕を予防しまたは
その進行を阻止する口腔用剤に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an anti-caries agent, that is, an oral agent for preventing caries or inhibiting its progression.

近年、鮎蝕すなわち虫歯の罹患率は著しく増大しており
、大きな社会問題にまで発展している。
In recent years, the prevalence of tooth decay, or dental caries, has increased significantly and has developed into a major social problem.

一方、これに伴って1蝕の原因の研究も進んでおり、現
在の定説では1蝕の原因は食物中の蔗糖が1蝕原因菌の
作用により変化を受は不溶性かつ粘着性のグルカンを生
成することにあるとされている。このようにして生成さ
れたグルカンによって鮎蝕原因菌が歯面に付着して増殖
し歯垢を形成する。そして、この歯垢をベースとしてそ
の中の細菌が糖発酵により酸を発生し、その酸により1
蝕が進行するのである。1蝕の防止には歯の抵抗性を高
める方法、蔗糖を排除するか、蔗糖に代わる甘味料を使
用する方法、蔗糖より生成する不溶性のグルカンを分解
するかまたはグルカンの生成を阻止する方法もしくは結
節原因菌を撲滅する方法等が考えられる。上記の方法に
はそれぞれ長所欠点を備えているが鮎蝕の本質が1蝕原
因菌による感染症であるため、この原因となる結節原因
菌を撲滅することが結節防止に最も効果的であると考え
られる。上記の菌としてはストレプトコッカスミュータ
ンス(5treptococcus Mutans )
やストレプトコッカスサンダイス(5treptoco
ccus Sanguis)があげられる。結節防止の
ためにこのような1蝕原因菌を駆逐しようとするこころ
みはこれまでも数多くなされている。例えばペニシリン
やエリスロマイシン等の抗生物質、鮎蝕原因菌の細胞壁
を溶解する細胞壁溶解酵素やシクロヘキシジン等の殺菌
剤の使用がところみられている。しかしながら、これら
は口腔内および腸内細菌叢の撹乱により自然の細菌バラ
ンスを壊し、しかも副作用を惹起するという問題がある
。このような副作用の問題の解決がなされていないため
広く用いられるには致ってい彦い。したがって、もつか
のところ結節防止のために決定的な方法がないのが実情
であり、食後、はぶらしで清掃するという物理的な方法
に勝る予防法の確立がなされていないのが現状である。
On the other hand, research into the cause of 1st eclipse is progressing, and the current theory is that sucrose in food undergoes changes due to the action of 1st eclipse-causing bacteria, producing insoluble and sticky glucan. It is said that there is something to do. Due to the glucans produced in this way, bacteria that cause tooth decay adhere to the tooth surface and multiply to form dental plaque. Using this plaque as a base, the bacteria within it generate acid through sugar fermentation, and the acid produces 1
The eclipse progresses. 1. To prevent cavities, there are methods to increase the resistance of teeth, methods to eliminate sucrose or use sweeteners in place of sucrose, methods to decompose insoluble glucan produced from sucrose, or methods to block the production of glucan. Possible methods include eradicating nodule-causing bacteria. Each of the above methods has its advantages and disadvantages, but since the essence of ayu caries is an infection caused by bacteria that cause caries, the most effective way to prevent nodules is to eradicate the nodule-causing bacteria that cause this. Conceivable. The above bacteria include Streptococcus mutans
and Streptococcus sandeis (5treptococcus
ccus Sanguis). In order to prevent nodules, many attempts have been made to eliminate such bacteria that cause cavities. For example, antibiotics such as penicillin and erythromycin, cell wall lytic enzymes that lyse the cell walls of bacteria that cause Ayu erosion, and fungicides such as cyclohexidine are sometimes used. However, these have the problem of disrupting the natural bacterial balance by disturbing the oral and intestinal flora, and causing side effects. Since the problem of such side effects has not been solved, it is not suitable for widespread use. Therefore, the reality is that there is no definitive method for preventing nodules, and no preventive method has been established that is superior to the physical method of cleaning with a towel after meals. be.

本発明者らは、このような事情に鑑み1蝕の防止を1指
して一連の研究を重ねているうち、ある種の香料に抗菌
作用があるととにヒントを得て、香料を抗結節剤として
用いられないかと厖大な数の香料を対象とし、長期間に
渡って一連の研究を進めてきた。その結果、合成香料を
その!、−1用いるか、もしくは合成香料とカルボン酸
、ラクトンのような着香料(食品香料)を適宜に組み合
わせると優れた1蝕原因菌殺菌効果が得られるようにな
ることを見いだしこの発明に到達した。すなわち、この
発明は、合成香料のみか、もしくは合成香料と下記の抗
結節成分AおよびBの少なくとも一方とからなることを
特徴とする抗帖蝕剤をその要旨とするものである。
In view of these circumstances, the inventors of the present invention have conducted a series of studies with the aim of preventing caries, and were inspired by the fact that certain fragrances have antibacterial effects. Over a long period of time, he conducted a series of research studies on a huge number of fragrances that could be used as agents. As a result, synthetic fragrances! , -1 or by appropriately combining a synthetic flavoring agent with a flavoring agent (food flavoring agent) such as a carboxylic acid or lactone, an excellent bactericidal effect on bacteria that causes caries can be obtained, and this invention has been achieved. . That is, the gist of the present invention is an anti-corrosion agent characterized by comprising only a synthetic fragrance, or a synthetic fragrance and at least one of the following anti-nodulation components A and B.

A:カルボン酸 13:ラクトン このように、この発明は、副作用が全くなく安全性の極
めて高い香料成分を抗暉蝕剤として用いるところに最大
の特徴がある。
A: Carboxylic acid 13: Lactone As described above, the greatest feature of the present invention is that it uses an extremely safe fragrance ingredient with no side effects as an anti-corrosion agent.

つぎに、この発明の詳細な説明する。Next, this invention will be explained in detail.

従来から、香料化合物のある種のものには抗菌作用があ
るという報告が散見されている。しかしナカラ、最も強
い結節作用をもっミュータンス菌に対する抗菌活性に関
する報告は皆無である。そこで本発明者らは、先づ第1
段階として伺らがの抗菌作用が報告されているか比較的
汎用されている合成香料を対象としミュータンス菌に対
する抗菌活性を測定した。抗菌活性は、それぞれ上記合
成香料を5係のアルコール溶液としくこれを供試成分と
する)、これを、5%の蔗糖を含有するハートインフュ
ージョン培地に1/100〜1/l O00の割合(5
係アルコール溶液((供試成分))濃度が1/100〜
1/1000)になるように添加し、培地が固化したの
ち、ミュータンス菌(ストレプトコッカスミュータンス
RIMD 3125001 )を穿刺接種して37°C
で72時間以上培養し、培地中、培地表面における菌の
生育を観察して測定した。抗ミュータンス菌活性がある
ものは後記の第1表のとおりである。抗ミュタンス菌活
性があるということは、供試成分を171000の割合
になるように添加し、37°Cで72時間以上培養した
場合においてミュータンス菌の生育が認められないとい
うことである。そして、供試成分濃度をどんどん希釈し
テユキ、抗ミュータンス菌活性が認められる最少濃度(
有効生育阻止濃度)の逆数、例えば供試成分濃度が1/
1000であるときは、その逆数の1000を抗ミュー
タンス菌活性値として示した。対象用として厚朴エキス
、厚朴エキスの有効成分であるマグノロ−・しならびに
ミュータンス菌に対する殺菌作用をもつ抗生物質エリス
ロマイシンを用い、同様の実験を行って第1表に併せて
示しだ。第1表に掲げる合成香料は、抗飴蝕用剤として
知られている厚朴エキス(特開昭57−85319参照
)と同等かそれ以上の優れた抗ミュータンス菌活性を示
している。
There have been reports here and there that certain fragrance compounds have antibacterial effects. However, there are no reports regarding the antibacterial activity of Nacala against Streptococcus mutans, which has the strongest nodulation effect. Therefore, the present inventors first
As a step, we measured the antibacterial activity against S. mutans using synthetic fragrances that have been reported to have an antibacterial effect or are relatively widely used. The antibacterial activity was determined by adding the above synthetic fragrance to a 5% alcohol solution as the test component) and adding it to a heart infusion medium containing 5% sucrose at a ratio of 1/100 to 1/l O00. (5
Alcohol solution ((test component)) concentration is 1/100~
After the medium had solidified, mutans bacteria (Streptococcus mutans RIMD 3125001) was punctured and incubated at 37°C.
The cells were cultured for 72 hours or more, and the growth of the bacteria in the medium and on the surface of the medium was observed and measured. Those having anti-Streptococcus mutans activity are shown in Table 1 below. Having anti-Streptococcus mutans activity means that no growth of Streptococcus mutans is observed when the test components are added at a ratio of 171,000 parts and cultured at 37°C for 72 hours or more. Then, the concentration of the test component was diluted rapidly, and the minimum concentration at which anti-Streptococcus mutans activity was observed (
The reciprocal of the effective growth inhibitory concentration), for example, the concentration of the test component is 1/
When the value was 1000, the reciprocal of 1000 was shown as the anti-mutans activity value. Similar experiments were conducted using Atsuboku extract, the active ingredient of Atsubaku extract, Magnolia nigra, and erythromycin, an antibiotic that has a bactericidal effect against Streptococcus mutans, and are shown in Table 1. The synthetic fragrances listed in Table 1 exhibit excellent anti-Streptococcus mutans activity equivalent to or superior to that of Koboku extract (see JP-A-57-85319), which is known as an anti-candy agent.

このように、合成香料が極めて抗ミュータンス菌活性に
富んでいることより探索範囲をカルボン酸およびラクト
ンのような着香料の分野まで広げて抗ミュータンス菌活
性のある物質を調べた。その結果は後記の第2表のとお
りである。第2表に掲げるカルボン酸およびラクトン群
が極めて高い抗ミュータンス菌活性を備えていた。
Since synthetic fragrances are extremely rich in anti-Streptococcus mutans activity, we expanded our search to the field of flavoring agents such as carboxylic acids and lactones to investigate substances with anti-Streptococcus mutans activity. The results are shown in Table 2 below. The carboxylic acids and lactones listed in Table 2 had extremely high anti-Streptococcus mutans activity.

つぎに、上記第1表および第2表に示す香料成分を混合
してその抗ミュータンス菌活性ヲ調べだ。
Next, the fragrance ingredients shown in Tables 1 and 2 above were mixed and their anti-mutans activity was investigated.

その結果は後記の第3表に示すとおりであり、それぞれ
第1表および第2表の香料成分の抗ミュータンス菌活性
値の相加平均よりも高い抗ミュータンス菌活性値が得ら
れた。これは第1表および第2表に示す香料成分を混合
することにより大きな相乗効果がイ4fられることを示
している。すなわち、一般に、香料成分は単独で使用さ
れることは稀であり、各種の成分を調合して所望の香り
の混合香料をつくり、とれを使用することが行われてい
る。
The results are shown in Table 3 below, and the anti-Streptococcus mutans activity values were higher than the arithmetic mean of the anti-Streptococcus mutans activity values of the fragrance ingredients in Tables 1 and 2, respectively. This shows that a great synergistic effect can be achieved by mixing the fragrance ingredients shown in Tables 1 and 2. That is, in general, fragrance ingredients are rarely used alone, and various ingredients are mixed to create a mixed fragrance with a desired fragrance, and the resulting mixture is used.

したがって、第1表および第2表に示す香料成分を混合
して用いることにより第3表に示すような大きな相乗効
果が得られるようになるということは実用上極めて有効
である。
Therefore, it is extremely effective in practice that the large synergistic effects shown in Table 3 can be obtained by mixing and using the fragrance ingredients shown in Tables 1 and 2.

このように、この発明の抗結節剤は、食品業界等で幅広
く、実際に使用されている安全性の高い香料成分からな
るため副作用は全く生じない。すなわち、この発明の抗
結節剤は抗生物質であるエリスロマイシンに比べればそ
の抗結節作用がやや低いが、この発明の抗結節剤は抗生
物質ではないため抗生物質にみられるような副作用(体
内微生物相の撹乱、耐性菌の出現)がなく、長期間連用
しても全く問題はない。そのうえ、この発明の抗結節剤
は合成香料、カルボン酸、シフトン等幅広い範囲の香料
成分からなるため、適宜の香料成分を組み合わせて、抗
結節剤の添加の対象となる品物に任意の好ましい風味を
付与しうるようになる。
As described above, the anti-nodulation agent of the present invention does not cause any side effects because it is composed of highly safe flavor ingredients that are widely and actually used in the food industry and the like. In other words, the anti-nodulation agent of this invention has a slightly lower anti-nodulation effect than the antibiotic erythromycin, but since the anti-nodulation agent of this invention is not an antibiotic, it does not cause side effects (in vivo microflora) that are seen with antibiotics. (disturbance of bacteria, emergence of resistant bacteria), and there is no problem at all even if used continuously for a long period of time. Moreover, since the anti-nodulation agent of the present invention is comprised of a wide range of flavoring ingredients such as synthetic fragrances, carboxylic acids, and sifton, appropriate flavoring ingredients can be combined to impart any desired flavor to the product to which the anti-nodulation agent is added. It becomes possible to grant.

この効果は、抗結節剤の投与がある程度長期間に渡るこ
と、また、ことに結節予防のためには歯牙の助出がはじ
まる1才前後からの幼児における投与が望ましいことも
考え合わせると臨床実用上、極めて有用性の高いもので
ある。
This effect is clinically practical, considering that anti-nodulation agents can be administered for a fairly long period of time, and that to prevent nodules, it is desirable to administer them to infants from around 1 year of age, when tooth development begins. Moreover, it is extremely useful.

さらに、この発明の抗結節剤は極めて低濃度でミュータ
ンス菌の生育を駆出することができるため、微量の使用
量で大きな抗結節効果を得ることができる。
Furthermore, since the anti-nodulation agent of the present invention can stimulate the growth of S. mutans at an extremely low concentration, a large anti-nodulation effect can be obtained with a small amount of use.

このように、この発明の抗結節剤叫、香料成分であって
しかも微量の使用量で優れた抗結節効果が得られるため
、うがい薬、トローチ、はみかき。
As described above, the anti-nodule agent of the present invention is a fragrance ingredient that can have an excellent anti-nodule effect even when used in a small amount, so it can be used in gargles, troches, and toothpastes.

チューインガム等を賦香すると同時に抗結節効果も発揮
しつるのである。そして、その使用により従来の抗生物
質のような副作用が全く生じないのであり、長期間の連
用に充分に耐えうる極めて実用性の高いものである。し
かも、この発明の抗結節剤は、そのなかにすでに抗菌作
用を有するものとして知られているものを含んでいるが
、それらは大腸菌、赤痢菌などの病原菌に対して抗菌作
用を有していることが知られているだけであり、ミュー
タンス菌のような特殊な菌(連鎖状球菌の分類のいずれ
にも属しない)に対する抗菌作用に対しては全く知られ
ていないため、これまでのものから予見しえない優れた
効果を奏しうるといえるものである。
It not only adds flavor to chewing gum, but also has an anti-knot effect. Moreover, its use does not cause any side effects unlike those of conventional antibiotics, and it is highly practical as it can withstand long-term continuous use. Moreover, the anti-nodulation agent of this invention contains substances already known to have antibacterial effects, and these have antibacterial effects against pathogenic bacteria such as Escherichia coli and Shigella. However, there is nothing known about its antibacterial effect against special bacteria such as Streptococcus mutans (which does not belong to any of the streptococcal classifications). It can be said that it can produce excellent effects that cannot be foreseen.

(以 下 余 白) 第   2   表 つぎに、実施例について説明する。(Hereafter, extra white) Table 2 Next, examples will be described.

以下の実施例では混合により優れた相乗効果が得られる
第3表の混合物を用いて行った。
The following examples were carried out using the mixtures in Table 3, which give excellent synergistic effects when mixed.

〔実施例1〕 第3表に記載された気1の混合物を対象とし、これのミ
ュータンス菌活性を求めたところ、ミュータンス菌に対
する有効生育阻止濃度は1/4000(抗ミュータンス
菌活性4ooo )であった。との&l混合物の5チア
ルコール溶液を濃度10チの蔗糖溶液に1/4000の
割合で添加して口に含んでも違和感および刺激は全く感
じられなかった。
[Example 1] When the Streptococcus mutans activity was determined for the mixture of Qi 1 listed in Table 3, the effective growth-inhibiting concentration against the Streptococcus mutans was 1/4000 (anti-Streptococcus mutans activity 4oooo). )Met. Even when a 5-thialcohol solution of the &l mixture was added to a 10-thiol sucrose solution at a ratio of 1/4000 and put into the mouth, no discomfort or irritation was felt at all.

〔実施例2〕 第3表の隘2の混合物を対象とし、これのミュータンス
菌に対する有効生育阻止濃度を調べたところその有効生
育阻止濃度は1/6000 (抗ミュータンス菌活性6
000 )であった。この混合物の5チアルコール溶液
を濃度10チの蔗糖溶液に176000の割合で添加し
て口に含んでも違和感および刺激は全く感じられなかっ
た。
[Example 2] The effective growth-inhibiting concentration against S. mutans was investigated using the mixture in column 2 of Table 3. The effective growth-inhibiting concentration was 1/6000 (anti-mutans activity 6
000). Even when a 5-thiol alcohol solution of this mixture was added to a 10-thiol sucrose solution at a ratio of 176,000 and taken in the mouth, no discomfort or irritation was felt at all.

〔実施例3〕 第3表の気3の混合物を対象とし、そのミュータンス菌
に対する有効生育阻止濃度を求めた。このものの有効生
育阻止濃度は1/6000 (抗ミュータンス菌活性6
000 )であった。この混合物の5チアルコール溶液
を濃度10%の蔗糖溶液に1/6000の割合で添加し
て口に含んでも違和感および刺激は全く感じられ々かっ
た。
[Example 3] The effective growth-inhibiting concentration against Streptococcus mutans was determined for the mixture 3 in Table 3. The effective growth inhibitory concentration of this substance is 1/6000 (anti-Streptococcus mutans activity 6
000). Even when a 5-thialcohol solution of this mixture was added to a 10% sucrose solution at a ratio of 1/6000 and placed in the mouth, no discomfort or irritation was felt at all.

〔実施例4〕 第3表の患4の混合物を対象とし、この混合物のミュー
タンス菌に対する有効生育阻止濃度を求めた。その結果
、有効生育阻止濃度は176000(抗ミュータンス菌
活性6000 )であった。そして、このものの5%ア
ルコール溶液を濃度10%の蔗糖溶液にl/6000の
割合で添加して口に含んでも違和感および刺激は全く感
じられなかった。
[Example 4] Using the mixture of patient 4 in Table 3, the effective growth-inhibiting concentration of this mixture against S. mutans was determined. As a result, the effective growth-inhibiting concentration was 176,000 (anti-Streptococcus mutans activity 6,000). Even when a 5% alcohol solution of this product was added to a 10% sucrose solution at a ratio of 1/6000 and placed in the mouth, no discomfort or irritation was felt at all.

特許出願人カネボウ食品株式会社 代理人 弁理士 西 藤 征 彦 手続補正書 (自発) 昭和58年5月23日 特許庁長官 殿 1、事件の表示 昭和58年特許願第51201号 2 発明の名称 抗結節剤 3、補正をする者 事件との関係  特許出願人 7、補正の内容 (1)明細書第10頁第1表を下記のとおり訂正する。Patent applicant Kanebo Foods Co., Ltd. Agent: Patent Attorney Yukihiko Nishifuji Procedural amendment (voluntary) May 23, 1982 Commissioner of the Patent Office 1. Display of incident 1981 Patent Application No. 51201 2 Name of the invention anti-knot agent 3. Person who makes corrections Relationship to the case Patent applicant 7. Contents of correction (1) Table 1 on page 10 of the specification is corrected as follows.

記 (2)明細書第11頁第2表の左側の枠の物質名の欄の
第3行目において、「ミスチリン酸」とあるをrミリス
チン酸」と訂正する。
Note (2) In the third line of the substance name column in the left frame of Table 2 on page 11 of the specification, "mystilic acid" is corrected to "r-myristic acid."

(3)明細書第11頁第2表の左側の枠の物質名の欄の
第5行目において、「ステアリン酸」とあるを「ステア
リン酸」と訂正する。
(3) In the 5th line of the substance name column in the left frame of Table 2 on page 11 of the specification, "stearic acid" is corrected to "stearic acid."

Claims (4)

【特許請求の範囲】[Claims] (1)合成香料のみかもしくは合成香料と下記の抗鮎蝕
成分AおよびBの少なくとも一方とからなることを特徴
とする抗鮎蝕剤。 A:カルボン酸 B:ラクトン
(1) An anti-ayu caries agent characterized by comprising only a synthetic fragrance or a synthetic fragrance and at least one of the following anti-ayu cariogenic ingredients A and B. A: Carboxylic acid B: Lactone
(2)合成香料が、タレジルブセテート、シクラメンア
ルデヒド、インオイゲノール、メチルオイゲノール、へ
りオトロビン、エチルサリシレート。 n−デカオールおよびP−メチルアセトフェノンからな
る群から選ばれた少なくとも一つの合成香料である特許
請求の範囲第1項記載の抗鮎蝕剤。
(2) Synthetic fragrances include talesylbuscetate, cyclamen aldehyde, ineugenol, methyleugenol, heliothrobin, and ethyl salicylate. 2. The anti-acillus caries agent according to claim 1, which is at least one synthetic fragrance selected from the group consisting of n-decaol and P-methylacetophenone.
(3)抗帖蝕成分Aのカルボン酸が、カプリン酸。 ラウリン酸、ミリスチン酸、バルミチン酸、ステアリン
酸、オレイン酸、リノール酸、ロジン酸。 バニリン酸、ウンデカン酸、ウンデカン酸および!ナン
ド酸からなる群から選ばれた少なくとも一つのカルボン
酸である特許請求の範囲第1項記載の抗鮎蝕剤。
(3) The carboxylic acid of anti-corrosion component A is capric acid. Lauric acid, myristic acid, valmitic acid, stearic acid, oleic acid, linoleic acid, rosin acid. Vanillic acid, undecanoic acid, undecanoic acid and! The anti-sweetfish corrosion agent according to claim 1, which is at least one carboxylic acid selected from the group consisting of nando acids.
(4)抗鮎蝕成分Bのラクトンが、d−デカラクトン、
d−ドデカラクトン、d−ウンデカラクトン、d−)リ
デカラクトンおよびd−テトラデカラクトンからなる群
から選ばれた少なくとも一つのラクトンである特許請求
の範囲第1項記載の抗鮎蝕剤。
(4) The lactone of the anti-sweetfish corrosion ingredient B is d-decalactone,
2. The anti-corrosion agent according to claim 1, which is at least one lactone selected from the group consisting of d-dodecalactone, d-undecalactone, d-)ridecalactone, and d-tetradecalactone.
JP5120183A 1983-03-26 1983-03-26 Cariostatic agent Granted JPS59175423A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5120183A JPS59175423A (en) 1983-03-26 1983-03-26 Cariostatic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5120183A JPS59175423A (en) 1983-03-26 1983-03-26 Cariostatic agent

Publications (2)

Publication Number Publication Date
JPS59175423A true JPS59175423A (en) 1984-10-04
JPH0567608B2 JPH0567608B2 (en) 1993-09-27

Family

ID=12880276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5120183A Granted JPS59175423A (en) 1983-03-26 1983-03-26 Cariostatic agent

Country Status (1)

Country Link
JP (1) JPS59175423A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384646B2 (en) 2002-09-26 2008-06-10 Mandom Corporation Antiseptic disinfectant, and cosmetics and toiletries, medicine or food containing the same
US7632871B2 (en) 2002-09-26 2009-12-15 Mandom Corporation Methods of making and methods of using antiseptic disinfectant, cosmetic and toiletries, medicine or food containing the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5929618A (en) * 1982-08-11 1984-02-16 T Hasegawa Co Ltd Preventing agent for carious tooth
JPS5929619A (en) * 1982-08-11 1984-02-16 T Hasegawa Co Ltd Preventing agent for carious tooth

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5929618A (en) * 1982-08-11 1984-02-16 T Hasegawa Co Ltd Preventing agent for carious tooth
JPS5929619A (en) * 1982-08-11 1984-02-16 T Hasegawa Co Ltd Preventing agent for carious tooth

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384646B2 (en) 2002-09-26 2008-06-10 Mandom Corporation Antiseptic disinfectant, and cosmetics and toiletries, medicine or food containing the same
US7632871B2 (en) 2002-09-26 2009-12-15 Mandom Corporation Methods of making and methods of using antiseptic disinfectant, cosmetic and toiletries, medicine or food containing the same
US7754774B2 (en) 2002-09-26 2010-07-13 Mandom Corporation Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides

Also Published As

Publication number Publication date
JPH0567608B2 (en) 1993-09-27

Similar Documents

Publication Publication Date Title
EP1776944A1 (en) Antimicrobial flavor and oral care composition containing the same
JPH0140005B2 (en)
JPS61171423A (en) Drug for alleviating dental caries and periodontosis
JP3614479B2 (en) Periodontal disease-causing bacteria or caries-causing bacteria inhibitor, oral composition and food containing them
WO2005091937A2 (en) Compositions useful for the treatment of microbial infections
KR101790034B1 (en) Oral composition for preventing cavity and halitosis
US20200179258A1 (en) Compositions, uses and methods for treating or preventing dental caries
JPH1143442A (en) Legionella bacteria resistant composition
JPS59175422A (en) Cariostatic agent
JPS59175426A (en) Cariostatic agent
KR20150061762A (en) Oral composition having anti-detal caries efficacy
JP7445910B2 (en) Oral compositions, oral care products, and foods containing oral resident bacteria regulators
JPS59175423A (en) Cariostatic agent
US20040265247A1 (en) Mouth rinse composition
KR20180118994A (en) Composition for preventing or alleviating or treating dental caries or periodontal disease by growth of oral pathogen
CN104997831A (en) Oral spray and preparation method thereof
JPS5835484B2 (en) Oral composition
JPH0320364B2 (en)
Nividita Puri Holistic approach of oil pulling in the dental world A literature review
KR20140055885A (en) The gargle composites for the increment of the oral care
JP6921655B2 (en) Protease inhibitors, biofilm formation inhibitors, and oral compositions
Sriram et al. Effectiveness of green tea on oral health in children.
JP2017171610A (en) Oral malodor inhibitory composition
Benly Comparison of the Bacterial Level by Pre Brushing and Post Brushing using Herbal and Fluoridated Toothpaste
JP2021065176A (en) Agent for inhibiting oral cavity pathogenic bacterium from growing, composition for oral cavity, and accelerator